Monthly Archives: May 2014

NY Times Editorial Underscores AHF Concerns on HIV Prevention Pill

Following the CDC’s release earlier this week of its public recommendation for widespread scale-up of the controversial HIV prevention strategy known as pre-exposure prophylaxis (PrEP), a May 15 New York Times editorial raises several significant concerns regarding the use of Truvada as PrEP as a possible method of HIV prevention. The editorial echoes grave concerns…

AHF breaks ground to extend clinic program in South Africa

AIDS Healthcare Foundation (AHF) broke ground on the first South African clinic to be build from the ground up – Foundation has been providing care in the country since 2002, supports 34 clinics countrywide Enhancing its services in South Africa, where it currently provides HIV/AIDS care and treatment to over 45,000 individuals, representatives from the…

New AHF Clinics Open in Zambia & Kenya

AIDS Healthcare Foundation cut ribbons on two new state-of-the-art HIV treatment clinics in Africa this week, with free healthcare centers built from the ground up in the capital cities of Lusaka, Zambia and Nairobi, Kenya AIDS Healthcare Foundation (AHF) proudly opened two new clinics in Africa in the second week of May, both of which…

CDC ‘ill-advised’ to promote Gilead’s PrEP as HIV prevention

WASHINGTON (May 14, 2014) AIDS Healthcare Foundation (AHF), the nation’s largest HIV/AIDS nonprofit medical provider blasted the Centers for Disease Control (CDC) for its ill-advised decision earlier today to recommend the widespread deployment of pre-exposure prophylaxis (PrEP)—the use of an AIDS treatment medication known as Truvada as a tool for HIV prevention in uninfected individuals….

Aids treatment is complacent

originally posted in IOL News , By Zohra Mohamed Teke Durban – South Africa must urgently ensure it has adequate capacity to treat the more than 5 million people living with HIV in the country – or risk becoming a victim of its own success story. That’s the strong warning from Michael Weinstein, president of the…

WSJ Ad asks Gilead Sovaldi Patients, Insurers: “If You Think $1,000 a Pill is OK, Stop Reading This.”

Advocacy ad running in the May 7th Wall Street Journal—the day of Gilead’s AGM—chides Gilead on the price of its new Hepatitis C medication Sovaldi—$84,000 for a twelve-week course or $1,000 a pill.   At the AGM, a shareholder resolution, ‘Patient Access as a Criterion of Executive Compensation,’ which was put forth by Gilead shareholder…

Activists address Pasadena City Council over Health Director’s Hate Speech

Roughly 25 activists from AIDS Healthcare Foundation joined the organization’s president, Michael Weinstein, in addressing the Pasadena City Council on Monday over ongoing incendiary remarks demonizing homosexuality made by Dr. Eric Walsh – AHF supports growing call for Walsh’s removal as city’s Public Health Director PASADENA (May 6, 2014) – Activists from the Los-Angeles based…